1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Diabetic Angiopathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaba, K; Kasuga, M; Kojima, H; Kusunoki, H; Liu, BF; Miyata, S; Miyazaki, H; Ohara, T; Suzuki, K; Uriuhara, A; Yamashita, Y | 1 |
| Colwell, JA | 1 |
| Cominacini, L; Fratta Pasini, A; Garbin, U; Lo Cascio, V | 1 |
| Armani, U; Carrubba, M; Leoncini, G; Piana, A; Signorello, MG | 1 |
| Anfossi, G; Burzacca, S; Cavalot, F; De Facis, R; Lucchina, PG; Massucco, P; Mattiello, L; Mularoni, E; Trovati, M | 1 |
| Arese, P; Biffignandi, P; Bussolino, F | 1 |
| Porcellini, G | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Diabetic Angiopathies
| Article | Year |
|---|---|
Studies on the pathogenesis of diabetic vascular disease.
Topics: Diabetes Mellitus; Diabetic Angiopathies; Endothelium; Humans; Lipids; Lipoproteins; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Prostaglandins | 1981 |
Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Blood Platelets; Calmodulin; Capillary Permeability; Chemical Phenomena; Chemistry; Cyclic AMP; Diabetic Angiopathies; Endothelium; Humans; Microcirculation; Neutrophils; Platelet Activating Factor; Steroids; Thrombosis | 1986 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Diabetic Angiopathies
| Article | Year |
|---|---|
Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Biomarkers; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Glycated Hemoglobin; Glycosylation; Humans; Middle Aged; Platelet Activating Factor; Reference Values | 2003 |
Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; E-Selectin; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Platelet Activating Factor; Reference Values; Risk Factors; Vascular Cell Adhesion Molecule-1 | 1996 |
Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients.
Topics: Adenosine Diphosphate; Aged; beta-Thromboglobulin; Blood Platelets; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Free Radicals; Humans; Hydrogen Peroxide; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Risk Factors; Thrombin; Thrombosis | 1997 |
Moderate exercise increases platelet function in type I diabetic patients without severe angiopathy and in good control.
Topics: Adenosine Diphosphate; Adult; beta-Thromboglobulin; Blood Glucose; Blood Platelets; Collagen; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Eating; Epinephrine; Exercise; Growth Hormone; Humans; Hydrocortisone; In Vitro Techniques; Insulin; Male; Norepinephrine; Platelet Activating Factor; Platelet Activation | 1992 |
[Platelet-activating factor: a new biochemical and pharmacologic frontier].
Topics: Animals; Capillary Permeability; Chemical Phenomena; Chemistry; Diabetic Angiopathies; Leukocytes; Platelet Activating Factor; Rabbits | 1986 |